Posted by AGORACOM-JC
at 4:16 PM on Thursday, February 28th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
Starbucks could be the first big chain to start selling CBD beverages
Coffee behemoth Starbucks could be the first major chain to introduce a range of cannabis-infused beverages, according to analysts.
A report released Monday by Cowan revealed its analysis of the CBD market.
The group believes that by 2025, CBD retail sales could reach up to $16 billion and that CBD is likely to start showing up in a variety of products on the market.
“The dynamics are fluid, likely delaying adoption from major
coffee players like Starbucks in the near term,†wrote analyst Andrew
Charles in the report.
“Should the regulation of CBD oil as an additive to food/beverage
change or craft/independent coffee shops find a way to comply with the
existing regulation, we could envision Starbucks ultimately piloting the
ingredient.â€
Despite the analysts’ projections, however, Starbucks-branded CBD
drinks may not be in the cards–at least for some time. Starbucks CEO
Kevin Johnson told CNBC
in January that while the coffee giant is keeping an eye on the trend,
cannabis drinks aren’t something the company is planning on rolling out
in the near future.
If the caffeine purveyors opt to incorporate cannabis beverages into
product lines, they face heavy regulations that may not be worth it–at
least in Canada.
All cannabinoids, including CBD, must be sourced from a
licenced producer, and regulators still aren’t sure how to deal with
potential age restrictions.
Nonetheless, there’s money to be made, so in a few years, there might
just be a CBD Frappuccino available to enthusiasts. See you in 2025!
Tags: CBD, Hemp, stocks, tsx, tsx-v Posted in North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Starbucks could be the first big chain to start selling CBD beverages $SBUX $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
Posted by AGORACOM-JC
at 3:45 PM on Tuesday, February 26th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
A Wall Street bank just started covering 7 marijuana stocks. Here’s what it’s saying
Last year was a historic one for legal-marijuana proponents due to legalization in Canada and some US states.
Marijuana stocks are popular on Robinhood, a free-trading app popular among millennials.
On Monday, Jefferies became the second major Wall Street investment bank to write sell-side notes on popular weed companies.
A Wall Street bank has officially initiated coverage of cannabis
stocks, as high-flying cannabis companies have caught the attention of
both the Main Street and Wall Street following a wave of marijuana
legalization.
Last year was a historic one for legal-marijuana proponents. Canada and the state of Michigan legalized the recreational use of marijuana, and the US Congress passed the Farm Bill, which legalized hemp, a key source of the ingredient cannabidiol.
Additionally, major marijuana producers such as Cronos Group, Canopy Growth, Tilray, and Aurora Cannabis
were listed in the US last year, prompting investors, especially
younger ones, to pour money into the industry. On Robinhood, a
free-trading app popular among millennials, Aurora has outranked all other stocks including Apple in terms of the number of users who own shares.
As the demand for market insights into marijuana stocks grows,
Jefferies analysts Owen Bennett and Ryan Tomkins have started to write
sell-side notes on popular weed companies. Jefferies is the second major
Wall Street investment bank to cover the industry, after Cowen.
Tags: Hemp, stocks Posted in All Recent Posts, North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – A Wall Street bank just started covering 7 marijuana stocks. Here’s what it’s saying $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca
Posted by AGORACOM-JC
at 8:49 AM on Tuesday, February 26th, 2019
Announced that the United States Patent and Trademark Office issued the Company a patent for the formulation of its flagship CBD product, hempSMART™ Brain.
hempSMART Brain is a wellness product formulated with a proprietary composition of natural ingredients and cannabidiol (CBD) for the enhancement of brain function.
Escondido, California–(February 26, 2019) – MARIJUANA COMPANY OF AMERICA INC. (OTCQB: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is proud to announce that the United States Patent and Trademark Office issued the Company a patent for the formulation of its flagship CBD product, hempSMART™ Brain.
hempSMART Brain is a wellness product formulated with a proprietary
composition of natural ingredients and cannabidiol (CBD) for the
enhancement of brain function. The U.S. Patent Office issued patent
number 10,201,553. To view the patent on hempSMART™ Brain visit the link here.
Dianna Steinberg, Head of Product Development, commented, “This
patent represents the hard work of the whole team involved in this
formulation. Their invaluable insight into the goal of using CBD with
additional supplements in a synergistic fashion to produce a fabulous
product is a tribute to their dedication.”
Donald Steinberg, CEO, commented, “This patent award signifies
advances we achieved and are continuing to work toward as a company to
produce products of the highest quality. As we continue to build the
hempSMART brand on a global basis, our receipt of this patent will
provide the Company with recognition of the advances being made at
Marijuana Company of America.”
Trevor Muehlfelder, Legal Project Manager on the patent application
for H Smart Inc., observed: “Having been involved with this application
from the beginning, it is rewarding to see the U.S. Patent Office
recognize the unique and innovative values of the Company’s personal
wellness products utilizing cannabidiol and other synergistic
ingredients. This is our first patent to date and corroborates the
Company’s continuing commitment to developing natural wellness products
utilizing CBD for everyone.”
About Marijuana Company of America, Inc. MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.
About Our hempSMART Products Containing CBD The
United States Food and Drug Administration (FDA) has not recognized CBD
as a safe and effective drug for any indication. Our products containing
CBD derived from industrial hemp are not marketed or sold based upon
claims that their use is safe and effective treatment for any medical
condition as drugs or dietary supplements subject to the FDA’s
jurisdiction.
Forward Looking Statements This
news release contains “forward-looking statements” which are not purely
historical and may include any statements regarding beliefs, plans,
expectations or intentions regarding the future. Such forward-looking
statements include, among other things, the development, costs and
results of new business opportunities and words such as “anticipate”,
“seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or
similar phrases may be deemed “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995. Actual
results could differ from those projected in any forward-looking
statements due to numerous factors. Such factors include, among others,
the inherent uncertainties associated with new projects, the future U.S.
and global economies, the impact of competition, and the Company’s
reliance on existing regulations regarding the use and development of
cannabis-based products. These forward-looking statements are made as of
the date of this news release, and we assume no obligation to update
the forward-looking statements, or to update the reasons why actual
results could differ from those projected in the forward-looking
statements. Although we believe that any beliefs, plans, expectations
and intentions contained in this press release are reasonable, there can
be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should consult all of
the information set forth herein and should also refer to the risk
factors disclosure outlined in our annual report on Form 10-12G, our
quarterly reports on Form 10-Q and other periodic reports filed from
time-to-time with the Securities and Exchange Commission. For more
information, please visit www.sec.gov.
For more information, please visit the Company’s websites at:
Posted by AGORACOM-JC
at 12:33 PM on Monday, February 25th, 2019
SPONSOR: Bougainville
Ventures Inc (CSE: BOG) Converting irrigated farmland to
greenhouse-equipped farmland. Bougainville does not “touch the plantâ€
and only provides agricultural infrastructure as a landlord for
licensed marijuana growers. Click here for more info.
BOG:CSE —————————————
Nearly 1 in 6 Canadians Have Used Marijuana Since Recreational Pot Was Legalized
New data from Statistics Canada offers an inside look at cannabis consumption rates based on province, gender, and age.
The sky seems to be the limit for the legal marijuana industry.
According to the most bullish forecast from Wall Street investment firm Cowen Group, the legal weed industry could surpass soda in global sales by 2030 and generate $75 billion in yearly revenue.
More immediately, a co-authored report from Arcview Market Research and BDS Analytics has called for 38% global sales growth in 2019 to $16.9 billion.
Sean Williams Feb 23, 2019 at 10:51AM
The sky seems to be the limit for the legal marijuana industry.
According to the most bullish forecast from Wall Street investment firm Cowen Group, the legal weed industry could surpass soda in global sales by 2030 and generate $75 billion in yearly revenue.
More immediately, a co-authored report from Arcview Market Research and
BDS Analytics has called for 38% global sales growth in 2019 to $16.9
billion. No matter how you analyze the data, that’s a lot of green to go
around; and it’s a big reason why pot stocks have been virtually
unstoppable since the year began.
Although the United States would represent the largest cannabis
market in the world by sales if it were legalized at the federal level,
it’s our northerly neighbor Canada that’s leading the charge on
marijuana reform. Having become the first industrialized country in the world,
and only second overall behind Uruguay, to legalize adult-use pot in
October, Canada looks to be on track for an estimated $5.9 billion in
annual sales by 2022.
Image source: Getty Images.
An inside look at the average Canadian cannabis user
But just how quickly are Canadians adapting to this legalized
environment? For that answer, I turn to Statistics Canada, the national
statistics office that gathers information on Canada’s economy,
environment, and society.
Recently (as of Feb. 21, 2019), Statistics Canada released self-reported data
on consumers’ use of cannabis over the past three months. As a
refresher, marijuana legalization occurred roughly four months ago,
although the first month was a supply-side disaster. That means the past
three months of use should give us a really good idea of what the
typical Canadian consumer looks like.
According to the data, which Statistics Canada will continue to
update, 15.4% of all citizens, or nearly 1 out of 6 Canadians, have used
cannabis over the past three months. As you can imagine, usage
statistics tend to vary by region, gender, and age. For instance, Quebec
had the lowest percentage of people using marijuana over the past three
months (13.6%), while the lesser-populated Nova Scotia had the highest
percentage by far at 21.6%. Newfoundland and Labrador and New Brunswick
were also significantly above the national self-reported average in
three-month use rates.
In terms of gender, men were significantly more likely than women (19.4% vs. 11.3%) to have consumed cannabis recently.
Finally, as you might expect, pot use over the past three months was
considerably higher among younger people than older folks. Overall,
27.4% of Canadians aged 15 to 24 and 23.2% of those aged 25 to 34 used
cannabis over the past three months. Meanwhile, just 5.2% of seniors
aged 65 and up and 10.4% of Canadians aged 55 to 64 used weed recently.
Even though the older generation has more disposable income, it’s these
younger adults that are the future of the legal weed industry.
Image source: Getty Images.
Cannabis consumption rates are likely to rise — here’s why
Although there were no major surprises here, there are some relatively interesting takeaways to be made.
For example, an average use rate of just 15.4% might seem rather low,
but it’s not factoring in two pretty important catalysts. First,
there’s the fact that marijuana growers are still in the early stages of
ramping up their production. Aurora Cannabis (NYSE:ACB), which is my selection to lead the country with 700,000 kilograms of peak annual production,
is only producing at an annual run rate of 120,000 kilos right now. By
the end of the current calendar quarter, Aurora Cannabis should be
yielding more than 150,000 kilos annually, but it’s going to take
perhaps 12 to 24 more months before Aurora is operating on all
cylinders. When consumers have access to ample demand and the per-gram
price for dried cannabis flower comes down a bit, we’re liable to see
usage rates increase.
The second catalyst is the expected legalization of new consumption
options by this fall. When the Cannabis Act was signed into law last
June, and legal product sales commenced on Oct. 17, 2018, it only
included dried flower, cannabis oil, and sprays. Alternative products
such as edibles and cannabis-infused beverages aren’t yet legal.
That, however, is expected to change by no later than Oct. 17, 2019,
according to an outline presented by Health Canada. Edibles and infused
beverages containing cannabidiol (CBD), the nonpsychoactive cannabinoid
best known for its medical benefits, are expected to be especially
important in luring in new users.
The provincial-use data is also interesting in that it highlights one potential under-the-radar grower: OrganiGram Holdings (NASDAQOTH:OGRMF). The New Brunswick-based OrganiGram is the only Atlantic grower expected to yield more than 100,000 kilograms
per year when at full production capacity. Its geographic location
gives it competitive advantages in New Brunswick, Nova Scotia, and
Newfoundland and Labrador. Sure, these are far less populated regions
than, say, Ontario or Quebec, but it nevertheless allows OrganiGram a
foothold in these potentially higher-use provinces and territories.
OrganiGram was already a value stock among its peers, but it’s now that
much more intriguing following the release of this data.
Image source: Getty Images.
I believe this data also demonstrates the scope of opportunity awaiting Shopify (NYSE:SHOP) and its e-commerce platform. A number of large growers and provinces, including Ontario,
have chosen to utilize Shopify’s sales platform for online and
brick-and-mortar sales. Aside from simply being the sales platform of
choice, Shopify offers marijuana companies purchasing data on consumers
for pretty much the first time ever. With this being a cash-dominated
industry, it’s been virtually impossible for growers and retailers to
understand their customer base. With Shopify, this is going to change,
and both producers and retailers will be able to more directly target
consumers.
Ultimately, the legal weed industry is still in its infancy in
Canada. That means we’re liable to see this data shift as Health Canada
adjusts the boundaries of what’s legal and growers and retailers come to
better understand their customers.
Posted by AGORACOM-JC
at 12:38 PM on Friday, February 22nd, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
Cannabis edibles, plant proteins and other food trends to watch for in 2019
Canada is high on cannabis edibles
Cannabis will soon be a major driver in the food and beverage category.
This year should see edible products incorporated into Bill
C-45 (the Cannabis Act), opening up opportunities for health foods and
supplements, snack foods, packaged meals, restaurants and tourism.
A recent Deloitte report found that 58 per cent of current Canadian cannabis users intend to consume edibles once they’re legalized.
Food continues to find its way into the consciousness of Canadians.
It’s in our news feed, on our television screens and, more and more,
part of our day-to-day conversations. The challenge is to separate the
fact from the fiction, the ephemeral from the soon-to-be everyday. The
University of Guelph’s newest Food Focus Trends Report highlights six key trends likely to be front and centre this year.
Flexitarians on the rise
While vegans and vegetarians get all the attention, the flexitarians
are rapidly growing in number — and in clout. A flexitarian is someone
who is eating less meat rather than giving it up entirely.
Almost 85 per cent of Canadians claim to eat at least one vegetarian
meal per month, with nearly 50 per cent saying they do so at least once a
week. Despite only seven to eight per cent of Canadians identifying as
vegetarian or vegan, the conscious consumption of flexitarians will
likely have a profound impact on the quantity and types of meat we eat
as well as spurring the growth of protein alternatives.
By choosing to eat less meat, consumers are likely to indulge in more premium cuts while sacrificing staples like ground beef.
Plant-based proteins are also sure to grow in popularity, as are
those from previously taboo sources, such as insects. Canada’s new Food Guide also recommends an increased focus on plant-based foods.
Should Canada’s meat industry be concerned? Possibly, but increased
international demand should keep overall prices in our country steady
for the foreseeable future and population growth here will also continue
to increase the total demand for meat.
Easing fears about gene-editing
If comic books and horror movies have taught the average Canadian
anything, it’s that nothing good ever comes from playing with genes.
Unfortunately, fiction can sometimes be more believable than facts.
When it comes to agriculture, gene editing increases yields, develops
tolerances to things like drought or pests, removes allergens (to make
gluten-free wheat, for example) and enhances nutritional quality.
And the biggest benefit
may be for the world’s poor. Basically, gene editing is doing what
animal and plant breeders have been doing for hundreds and hundreds of
years, only in a way that’s much faster, much cheaper and much more
specific.
The only challenge? Reducing unfounded fears and communicating the
incredible potential of genetically modified crops and foods in a way
that Canadians can fully embrace.
So shouldn’t we all be behind the bee? It’s not that simple.
While they are essential for some crops, other crops rely on methods
of pest control that are associated with the decline of pollinators.
As we’ve seen with the neonicotinoids debate, striking a delicate
balance between the needs of farmers and the protection of pollinators
is an ongoing challenge and a goal that will not be easily achieved.
Canada is high on cannabis edibles
Cannabis will soon be a major driver in the food and beverage
category. This year should see edible products incorporated into Bill
C-45 (the Cannabis Act), opening up opportunities for health foods and
supplements, snack foods, packaged meals, restaurants and tourism.
A recent Deloitte report found that 58 per cent of current Canadian cannabis users intend to consume edibles once they’re legalized.
But these highs do have some potential lows — work will need to be
done to ensure proper dosing and to prevent unintended secondary
consumption by children and pets.
As well, the path to market for cannabis products in Canada goes
through three different pieces of legislation: the Cannabis Act, the
Controlled Drugs and Substances Act and the Food and Drugs Act.
In addition, products for medical consumers must also meet the Access
to Cannabis for Medical Purposes Regulations that are included in the
Controlled Drugs and Substances Act. But with the total market estimated
at more than $7 billion (on par with Canada’s wine industry), the
future is nonetheless bright for cannabis companies.
Prospering in a time of protectionism
The whirlwind of trade deals and disputes in the past few years has
left many Canadians reeling. While there has been much hand-wringing
over inter-provincial barriers, NAFTA/USMCA and new agreements with
Europe and the Pacific Rim, freer trade in food has actually provided
Canadian farmers with markets that are hungry for our products.
Plus, Canadian consumers have benefited and now enjoy a wider range of affordable food products.
The one downside? Our regulated dairy industry, along with other
supply managed commodities, has ceded nearly 10 per cent of its market
through recent trade deals.
This will not only be painful for the dairy sector, but it isn’t
likely to result in lower prices for Canadians — although we will
probably see a broader array of cheeses and other dairy products.
Overall, though, trade has been good for Canada and will continue to be
for the foreseeable future.
Growing divide between food & farms
Farms may feed people, but they have very little to do with the price you pay for food.
Fluctuating prices of agricultural commodities like corn, wheat or
soybeans often fuel news stories but the reality is the increases in
food prices Canadians have seen over the years have been relatively
consistent.
Put simply, food and farm prices are not the same and the relationship between the two continues to weaken. Today, the farmers’ share
of the food dollar is around 20 per cent — higher for less processed
foods (nearly 50 per cent for eggs) and lower for more processed foods
(two per cent for corn, which is used as a sweetener in manufactured
food products).
While the effect of low commodity prices may be felt in farming
regions and associated industries, it has little impact on Canadians
when they’re checking off their grocery lists — and that isn’t expected
to change in 2019.
Posted by AGORACOM-JC
at 11:44 AM on Tuesday, February 19th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
Cannabis-Infused Beverages to Launch in Canada by This Fall
For some brand-name beverage companies, this launch date can’t come quickly enough.
Marijuana investors are bubbling over with excitement, and who can blame them as this once-taboo industry ramps up production and rolls out the red carpet for consumers
Last year, Canada wound up ending nine decades of recreational marijuana prohibition and became the first industrialized country in the world to give the green light to adult-use weed.
 Sean Williams (TMFUltraLong) Feb 19, 2019 at 7:21AM
Marijuana investors are bubbling over with excitement, and who can blame them as this once-taboo industry ramps up production and rolls out the red carpet for consumers.
Last year, Canada wound up ending nine decades of recreational
marijuana prohibition and became the first industrialized country in the
world to give the green light to adult-use weed. According to some
estimates, this should allow the Canadian weed industry to grow sales to
nearly $6 billion a year by 2022. Taking into account that two-thirds
of all U.S. states have legalized pot in some capacity, and Mexico is
getting ever closer to a broad-based legalization of weed, the North
American market is looking very conducive to investment.
Image source: Getty Images.
Most alternative marijuana products aren’t legal right now
However, the marijuana industry isn’t nearly as cut and dried as you
might think. It’s about more than simply growing dried cannabis flower
and selling it. In fact, if growers simply chose to focus on dried
flower, they’d probably get creamed if the U.S. states of Colorado,
Washington, and Oregon serve as an example. Over time, dried marijuana
flower becomes an oversupplied and commoditized product, leading to a
decline in per-gram pricing and reduced margins for those weed companies
that lack portfolio diversity.
In order to combat this, growers need to think outside the box. The
way they do this is by focusing on alternative cannabis product options,
such as cannabidiol (CBD) oils, vapes, sublingual sprays, lotions and
balms, edibles, and cannabis-infused beverages. These are significantly
higher-priced and higher-margin products than traditional dried flower,
and they’re far less susceptible to future pricing pressure relative to
dried cannabis.
But there’s just one problem: Most of these alternative products aren’t legal
— even in Canada. When the Cannabis Act was passed by Parliament,
dried flower, sublingual sprays, and cannabis oil were given the green
light, while edibles and infused beverages, arguably the two most
attractive means for retailers to drive foot traffic and lure in
first-time consumers, have remained illicit. Thankfully for growers and
investors, this is soon to change.
Recently, Health Canada outlined its game plan
on alternative consumption options. The goal, per the regulatory
agency, is to have all alternative cannabis products, with the exception
of infused beverages containing alcohol, approved for sale by no later
than Oct. 17, 2019, which would mark the one-year anniversary of
recreational weed going on sale in Canada. As such, brand-name beverage
companies and their cannabis partners are preparing for launch.
Image source: Getty Images.
Beverage makers and pot stocks are bubbling with anticipation
The expected release of cannabis-infused beverages can’t come a moment too soon for Molson Coors Brewing (NYSE:TAP), which became the first major beverage producer to announce a joint venture or partnership with a pot grower last year. The joint venture between Molson Coors and HEXO (NYSEMKT:HEXO), known as Truss, is expected to begin putting nonalcoholic cannabis-infused beverages on retailers’ shelves by this fall.
Last week, Molson Coors reported its fiscal fourth-quarter and
full-year earnings, and they demonstrated just how badly a spark is
needed for this company. Sales in the U.S. and Canada, which have
traditionally been its bread-and-butter markets, fell 7% and 5%,
respectively, on a constant-currency basis during the fourth quarter.
The company’s market share of the beer market in Canada has, in
particular, been falling precipitously for about a decade. With the
exception of the company’s limited but growing premium beer offerings,
its major beer brands have really been a drag. And as icing on the cake,
tax accounting errors forced it to restate its full-year 2016 and 2017
results.
Being able to work with HEXO to put a premium product in front of
consumers, and having 57.5% ownership in the Truss joint venture, with
HEXO owning the remainder, puts Molson Coors in the driver’s seat to
reap the rewards of an expanded beverage portfolio.
Image source: Getty Images.
The big question
What remains to be seen is if cannabis-infused beverages will actually be needle movers for any of the companies involved.
For a smaller company like HEXO, which is still in the relatively
early stages of ramping up production capacity and aiming for its 108,000 kilograms in peak annual output,
a 42.5% share of infused beverage sales come the fourth quarter of the
existing calendar year could be quite nice. With just over 75 million
Canadian dollars in sales expected in fiscal 2019, infused beverage
sales as a percentage of total sales will likely be higher at HEXO than
at any other company.
As for Molson Coors Brewing, this is a company that regularly
generates close to $11 billion in annual sales. Although it might be the
first beverage maker to have really dipped its toes into the pond, it
won’t be the last. Competition is building, and there are no guarantees
that it will provide much of a lift to the company’s sliding Canadian
sales. Mind you, I’m not faulting Molson Coors one iota for moving into
the cannabis space, which is a smart maneuver from a growth perspective.
But expecting infused beverages to be a panacea for its North American
sales slide is probably being far too optimistic.
Tags: Hemp, stocks, tsx Posted in North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca – Cannabis-Infused Beverages to Launch in Canada by This Fall $ACB $WEED.ca $HIP.ca
Posted by AGORACOM-JC
at 11:40 AM on Thursday, February 14th, 2019
WHY NORTHBUD FARMS?
Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
Infused products sector has become the highest margin segment of the industry
Positioned to be a raw input producer for this space
Currently working with multiple food,
beverage and science companies to provide safe standardized cannabinoid
infused raw inputs for large scale GMP manufacturing of products
Announced Creation of “1017†Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line
THE OPPORTUNITY
Acquired late stage ACMPR applicant GrowPros MMP from Tetra Bio-Pharma (TSXV: TBP)
GrowPros MMP application was submitted in November 2014 and is currently in the ‘Confirmation of Readiness’ stage.
Announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area
Posted by AGORACOM-JC
at 2:55 PM on Monday, February 4th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
New Cannabis Products Which Could Disrupt the Industry in 2019
If there is one large-scale category of cannabis product which is likely to emerge in 2019, it is edibles.
When Canada moved to legalize recreational marijuana usage among adults, it did not include regulations for edibles and other products which might be confused for non-cannabis alternatives
The cannabis industry enjoyed tremendous investor enthusiasm in 2018,
fueled in large part by major developments which seemed to open up the
space for new opportunities. Canadian legalization of recreational
marijuana use, the continued adoption of legal medical or recreational
cannabis in more states across the U.S., and high-profile achievements
from some of the industry’s emerging top contenders all fueled interest.
In spite of the fact that cannabis stocks overall failed to perform up
to expectations last year, 2019 has already revealed continued anticipation regarding this growing industry.
If cannabis stocks are to thrive going forward,
it’s likely that many companies will have some growing up to do.
Overextended balance sheets will need to be strengthened, highly
speculative mergers and acquisitions must be kept in check, and
quarterly figures will have to confirm that there is good reason for the
hype surrounding these companies.
One way that up-and-coming marijuana businesses can bolster their fortunes in 2019 is through the release of new cannabis-based products.
While it’s true that there has already been a flood of new marijuana
products to the market, it’s likely that only a few will emerge as
winners capable of driving sales and firming up particular companies’
dominant status in this fledgling market. Below, we’ll take a look at
some new cannabis products which may be able to change the game in this
way.
Edibles
If there is one large-scale category of cannabis product which is
likely to emerge in 2019, it is edibles. When Canada moved to legalize
recreational marijuana usage among adults, it did not include
regulations for edibles and other products which might be confused for
non-cannabis alternatives. The Canadian government allowed itself a
one-year window from the initial legalization date of October 17, 2018
to sort out regulations for edibles products. In the meantime, Canadian
marijuana companies have gotten a head start on developing new cannabis
edibles for retail sale, even as retailers are giving away product that
they are not yet allowed to sell. A recent survey indicated that about a quarter of Canadian cannabis customers had received a free edible in the last month.
When Canadian edibles become legal for retail sale on or before
October 17, 2019, expect a rush to get these products into retail shops.
Edibles alone could become a billion-dollar industry in the years to
come.
Cannabis Beverages
One of the biggest cannabis headlines of 2018 reported on news that Constellation Brands (STZ), the beverage company behind Corona and Modelo brand beers, had partnered with Canopy Growth Corp. (CGC),
the largest cannabis producer in Canada. The alignment of a major
cannabis company with a top producer of alcoholic beverages has many
analysts and investors speculating that there could be joint product
launches in the near future. Indeed, other pairs of companies have also
matched up in recent months as well: Molson Coors announced a partnership with Canadian producer HEXO also.
It’s unlikely that any existing products from companies like
Constellation and Molson will change because of these partnerships.
However, expect a THC-infused beverage market to crop up as a
subcategory of the larger edibles space. These products could include
THC- or cannabidiol (CBD)-infused juices, waters and seltzers or
coffees. CBD products may be marketed as “health” drinks aimed at
reducing anxiety and inflammation without generating a “high” feeling in
the same way that THC does.
Cannabidiol Products
Before 2018 was finished, CBD had already begun to make its way into
all manner of products for sale. Although cannabis includes dozens of
chemical components, CBD has emerged early on as a popular one for
extraction and subsequent inclusion in drinks, vaping products, bath
bombs and more. CBD has been marketed as a product with wide-ranging
health benefits which can help to cure everything from pain to insomnia.
While it’s difficult to say exactly how accurate this claim is, it has
nonetheless been sufficient to generate widespread interest in CBD, even
among consumers not interested in the traditional “high” associated
with cannabis. Expect a continued proliferation of CBD-based products in
the months to come. Beauty and skin care products are among the most
popular of these new offerings.
Cannabidiol has also made its way into drug treatments developed in
the medical marijuana space. Indeed, the first FDA-approved
cannabis-based drug makes use of a pharmaceutical CBD oil. Companies
like GW Pharmaceuticals (GWPH) and Cara Therapeutics (CARA)
are rushing to develop and test new CBD-based drug treatments. While
this process takes a much longer time than the development of retail
CBD-based products, it has the potential for tremendous industry-wide
staying power, not to mention the benefit of providing more evidence of
the efficacy of medical marijuana on a broader level.
Posted by AGORACOM-JC
at 3:51 PM on Wednesday, January 30th, 2019
WHY NORTHBUD FARMS?
Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
Infused products sector has become the highest margin segment of the industry
Positioned to be a raw input producer for this space
Currently working with multiple food,
beverage and science companies to provide safe standardized cannabinoid
infused raw inputs for large scale GMP manufacturing of products
Announced Creation of “1017†Distribution and Signing of a LOI to Acquire Janey’s Cannabis Line
THE OPPORTUNITY
Acquired late stage ACMPR applicant GrowPros MMP from Tetra Bio-Pharma (TSXV: TBP)
GrowPros MMP application was submitted in November 2014 and is currently in the ‘Confirmation of Readiness’ stage.
Announced the amendment of its licence application to add 500K SQ. FT. of outdoor cultivation area
Posted by AGORACOM-JC
at 9:55 AM on Wednesday, January 30th, 2019
SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high
quality cannabinoid production and procurement focusing on both
bio-pharmaceutical development and Cannabinoid Infused Products. Click Here For More Information
NBUD: CSE
—————
As marijuana firms flourish, Canadian exchange will hold lottery for the stock ticker POT
POT, previously the ticker for Potash Corp. of Saskatchewan before it merged with Agrium to form Nutrien, becomes available for use Feb. 1, 2019. (Richard Vogel/AP) Kristine OwramBloomberg NewsPrivacy Policy
The stock symbol POT is up for grabs on
Canadian exchanges, and demand is so high that a lottery is being held
for the first time ever to determine who gets it.
POT, previously
the ticker for Potash Corp. of Saskatchewan before it merged with Agrium
to form Nutrien, becomes available for use Friday. Not surprisingly,
the cannabis-themed symbol has attracted “significant interest,”
according to a staff notice published by the Toronto Stock Exchange.
Applications
from companies are due by 5 p.m. Tuesday in Toronto, and a random
lottery will be held Wednesday to determine the winner. TMX Group
spokeswoman Catherine Kee declined to comment on how many applications
it’s gotten, or how many of the interested companies are related to the
fast-growing cannabis sector.
POT isn’t the only marijuana-themed ticker symbol out there. Canopy Growth Corp.,
the world’s biggest cannabis company by market value, trades under the
symbol WEED in Canada and the ETFMG Alternative Harvest exchange-traded
fund uses the symbol MJ, short for Mary Jane. Other creative symbols
used by cannabis firms include TGIF, which belongs to 1933 Industries
Inc., and FSD Pharma’s HUGE.
The
POT lottery is open to companies listed on any Canadian exchange,
including the TSX, TSX Venture Exchange, Canadian Securities Exchange
and Aequitas NEO Exchange. Exchange-traded funds and issuers without an
active operating business aren’t eligible to participate.